全文获取类型
收费全文 | 378篇 |
免费 | 51篇 |
专业分类
429篇 |
出版年
2018年 | 4篇 |
2015年 | 11篇 |
2014年 | 8篇 |
2013年 | 8篇 |
2012年 | 11篇 |
2011年 | 12篇 |
2010年 | 7篇 |
2009年 | 12篇 |
2008年 | 10篇 |
2007年 | 19篇 |
2006年 | 15篇 |
2005年 | 16篇 |
2004年 | 11篇 |
2003年 | 15篇 |
2002年 | 22篇 |
2001年 | 4篇 |
2000年 | 7篇 |
1999年 | 5篇 |
1998年 | 6篇 |
1993年 | 4篇 |
1992年 | 10篇 |
1987年 | 4篇 |
1984年 | 5篇 |
1982年 | 4篇 |
1980年 | 11篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 6篇 |
1973年 | 8篇 |
1972年 | 6篇 |
1971年 | 9篇 |
1970年 | 5篇 |
1969年 | 4篇 |
1964年 | 4篇 |
1961年 | 3篇 |
1959年 | 4篇 |
1958年 | 4篇 |
1951年 | 3篇 |
1950年 | 3篇 |
1946年 | 4篇 |
1943年 | 7篇 |
1941年 | 3篇 |
1940年 | 3篇 |
1931年 | 4篇 |
1928年 | 3篇 |
1925年 | 3篇 |
1924年 | 3篇 |
1922年 | 3篇 |
排序方式: 共有429条查询结果,搜索用时 0 毫秒
131.
Frase H Smith CA Toth M Champion MM Mobashery S Vakulenko SB 《The Journal of biological chemistry》2011,286(16):14396-14409
The GES-2 β-lactamase is a class A carbapenemase, the emergence of which in clinically important bacterial pathogens is a disconcerting development as the enzyme confers resistance to carbapenem antibiotics. Tazobactam is a clinically used inhibitor of class A β-lactamases, which inhibits the GES-2 enzyme effectively, restoring susceptibility to β-lactam antibiotics. We have investigated the details of the mechanism of inhibition of the GES-2 enzyme by tazobactam. By the use of UV spectrometry, mass spectroscopy, and x-ray crystallography, we have documented and identified the involvement of a total of seven distinct GES-2·tazobactam complexes and one product of the hydrolysis of tazobactam that contribute to the inhibition profile. The x-ray structures for the GES-2 enzyme are for both the native (1.45 Å) and the inhibited complex with tazobactam (1.65 Å). This is the first such structure of a carbapenemase in complex with a clinically important β-lactam inhibitor, shedding light on the structural implications for the inhibition process. 相似文献
132.
133.
134.
Clyde N. White 《The Western journal of medicine》1915,13(8):330-331
135.
136.
137.
Andrew J. Mongue Megan E. Hansen Liuqi Gu Clyde E. Sorenson James R. Walters 《Molecular ecology》2019,28(10):2517-2530
Sperm are among the most variable cells in nature. Some of this variation results from nonadaptive errors in spermatogenesis, but many species consistently produce multiple sperm morphs, the adaptive significance of which remains unknown. Here, we investigate the evolution of dimorphic sperm in Lepidoptera, the butterflies and moths. Males of this order produce both fertilizing sperm and a secondary, nonfertilizing type that lacks DNA. Previous organismal studies suggested a role for nonfertilizing sperm in sperm competition, but this hypothesis has never been evaluated from a molecular framework. We combined published data sets with new sequencing in two species, the monandrous Carolina sphinx moth and the highly polyandrous monarch butterfly. Based on population genetic analyses, we see evidence for increased adaptive evolution in fertilizing sperm, but only in the polyandrous species. This signal comes primarily from a decrease in nonsynonymous polymorphism in sperm proteins compared to the rest of the genome, suggesting stronger purifying selection, consistent with selection via sperm competition. Nonfertilizing sperm proteins, in contrast, do not show an effect of mating system and do not appear to evolve differently from the background genome in either species, arguing against the involvement of nonfertilizing sperm in direct sperm competition. Based on our results and previous work, we suggest that nonfertilizing sperm may be used to delay female remating in these insects and decrease the risk of sperm competition rather than directly affect its outcome. 相似文献
138.
139.
140.
Mark CJ Tatchum-Talom R Martin DS Eyster KM 《American journal of physiology. Regulatory, integrative and comparative physiology》2007,293(5):R1969-R1975
Estrogens and selective estrogen receptor modulators (SERMs), such as raloxifene (RAL) and tamoxifen (TAM), acutely relax arteries, but the long-term effects of estrogens and SERMs on vascular reactivity in the mesenteric vasculature have not been well defined. In this study, we used an isolated, perfused mesenteric vascular bed technique to investigate the effect of chronic treatment of estrogens and SERMs on vascular reactivity of the mesenteric bed. Ovariectomized female Sprague-Dawley rats were treated by gavage with vehicle (control, 2-hydroxypropyl-beta-cyclodextrin), ethinyl estradiol, estradiol benzoate, equilin (EQ), TAM, or RAL for 3 wk. EQ and TAM increased vasoconstriction in response to all three vasoconstrictors tested (KCl, norepinephrine, and 5-HT). Ethinyl estradiol increased vasoconstriction in response to KCl and 5-HT, whereas responses to estradiol benzoate and RAL were less consistent. Only EQ (134 +/- 4 mmHg) and TAM (104 +/- 4 mmHg) changed mean arterial blood pressure compared with control (117 +/- 4 mmHg). These data demonstrate that 3-wk gavage treatment with estrogens and SERMs affects vascular reactivity in the mesenteric vascular bed. However, the three formulations of estrogen did not produce equivalent effects, and the effects of the SERMs were different from those of the estrogens. 相似文献